End-of-day quote Nasdaq 18:00:00 2024-07-01 EDT 5-day change 1st Jan Change
10.9 USD -13.22% Intraday chart for R1 RCM Inc. -13.42% +3.12%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Financial Shares Edge Lower -- Financials Roundup DJ
PE firm New Mountain values R1 RCM at nearly $6 bln in take-private deal RE
Private-equity firm New Mountain proposes R1 RCM buyout, WSJ reports RE
Sector Update: Financial Stocks Gain Late Afternoon MT
Sector Update: Financial Stocks Rise in Afternoon Trading MT
R1 RCM Shares Fall After New Mountain Lowers Takeover Offer MT
Transcript : R1 RCM Inc. - Special Call
Transcript : R1 RCM Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM
Transcript : R1 RCM Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM
Deutsche Bank Adjusts R1 RCM Price Target to $14 From $15, Maintains Hold Rating MT
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup DJ
R1 RCM Swings to Loss in Q1, Revenue Rises MT
Tranche Update on R1 RCM Inc.'s Equity Buyback Plan announced on November 2, 2021. CI
Transcript : R1 RCM Inc., Q1 2024 Earnings Call, May 08, 2024
R1 RCM Inc. Revises Earnings Guidance for the Year 2024 CI
R1 RCM Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says MT
North American Morning Briefing : Stock Futures -2- DJ
KeyBanc Downgrades R1 RCM to Sector Weight From Overweight on Potential Risks to Hospital End Markets MT
North American Morning Briefing : Traders Await -2- DJ
North American Morning Briefing : Investors -2- DJ
Canaccord Genuity Trims Price Target on R1 RCM to $16 From $17, Maintains Buy Rating MT
Citigroup Upgrades R1 RCM to Buy From Neutral, Price Target is $16 MT
R1 RCM Calls for Halt to Talks About Potential Deal MT
Transcript : R1 RCM Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 04:35 PM
Chart R1 RCM Inc.
More charts
R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
11.13 USD
Average target price
16.57 USD
Spread / Average Target
+48.89%
Consensus
  1. Stock Market
  2. Equities
  3. RCM Stock
  4. News R1 RCM Inc.
  5. Deutsche Bank Trims R1 RCM Price Target to $15 From $16, Maintains Buy Rating